Lea en español

Aptivus is the brand name for Tipranavir, or Tipranavir Disodium, manufactured and marketed by Boehringer-Ingelheim, and used in conjunction with other medications to treat HIV, or human immunodeficiency virus. The drug was first approved by the U.S. Food and Drug Administration (FDA) in 2005.
Tipranavir has been tied to a number of adverse health consequences, from bleeding in the brain and hepatitis to high blood sugar and diabetes. It has also been shown in clinical trials to increase cholesterol levels, as well as triglycerides.
To learn about your rights if you have experienced side effects after using Aptivus, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics